Latest Biotech News

Next-generation cell and gene therapies are driving a logistics overhaul because supply chains must protect living, patient-specific products through extremely tight stability windows. The...

Biopharma expansion is turning into a location-led competition as capacity constraints outpace timelines for new GMP facility builds. The industry is prioritizing ‘ready-now’ sites—areas with...

JACIE completed the first-ever inspection under its third edition Immune Effector Cells (IEC) Standards at Guy’s and St Thomas’ NHS Foundation Trust in Barcelona as the field expands certification...

Windward Bio raised $165 million to fund clinical trials targeting respiratory disorders, expanding its portfolio in asthma, COPD, and additional potential indications. The funding supports at...

Blackstone Life Sciences committed $250 million to Anagram Therapeutics, backing development of an oral enzyme replacement therapy for patients with exocrine pancreatic insufficiency. The deal...

enGene’s stock plunged after updated Phase II LEGEND trial data for its nonviral gene therapy detalimogene voraplasmid in high-risk, BCG-unresponsive nonmuscle invasive bladder cancer. Updated...

Researchers identified pharmacological markers that could refine oral PrEP dosing for men who have sex with men (MSM), according to work published in Nature Communications. The study focuses on...

A new post-hoc analysis set for presentation at the European Congress on Obesity (ECO 2026) will evaluate orforglipron, an oral GLP-1 receptor agonist, in adults aged 65 and older with obesity....

10x Genomics launched Atera, a new in situ spatial biology platform designed to deliver whole-transcriptome spatial analysis with single-cell sensitivity at scale. The company said Atera can...

Medicare spending on newly approved Alzheimer’s drugs Leqembi and Kisunla is tracking far below earlier projections, according to a CMS spokesperson cited by STAT+. Uptake has been so muted that...

enGene reported updated Phase II LEGEND trial data for its nonviral gene therapy detalimogene voraplasmid in high-risk, BCG-unresponsive nonmuscle invasive bladder cancer with carcinoma in situ...

Windward Bio secured $165M in financing to support clinical testing of long-acting antibodies targeting respiratory disorders. The raise is intended to advance a lead program in asthma and COPD,...

Neion Bio emerged from stealth with a platform concept to use genetically engineered chickens as protein “bioreactors,” aiming to replace much of the hardware-heavy biomanufacturing model built...

Reports claim Moderna has initiated early-stage research on a hantavirus vaccine, according to coverage cited in the article. The development reportedly moved investor sentiment, with Moderna...

Northwestern University researchers reported preclinical findings in mice suggesting metformin’s glucose-lowering effects are driven primarily by actions in gut cells rather than solely by hepatic...

A new post-hoc analysis is set to be presented at the European Congress on Obesity (ECO 2026) evaluating orforglipron in adults aged 65 and older with obesity, stratified by diabetes status. The...

Researchers reported findings that implicate epidermal MHC class II in coordinating NK-cell recruitment in psoriasis, with downstream effects involving pyroptosis in keratinocytes. The study is...

10x Genomics launched Atera, a new in situ spatial biology platform designed to deliver whole-transcriptome spatial analysis with single-cell sensitivity at scale. The company debuted Atera at the...

A new CRISPR safeguard approach described in the article aims to improve control over engineered microorganisms used in industrial biotechnology and biopharmaceutical production. The piece frames...

A team at Technical University of Munich (TUM) and Helmholtz Munich developed a method to repeatedly obtain updated genetic information from living cells without destroying them. The approach is...